NCT07380763

Brief Summary

This study compares two different methods of helping patients breathe by placing a tube in their airway (intubation) in an emergency setting. These methods are called Rapid Sequence Intubation (RSI) and Delayed Sequence Intubation (DSI). The study focuses on adult patients who are still breathing on their own but need a breathing tube for medical reasons not related to an injury (non-trauma). The main goal of the research is to compare:

  • Oxygen levels before and after the procedure.
  • The patient's vital signs (such as heart rate and blood pressure).
  • The number of attempts needed to successfully place the tube and the time the procedure takes.
  • Blood gas results and any complications that occur during or shortly after the procedure.
  • Early survival (mortality) rates. While there are previous studies on trauma patients or small observational reports, there is currently no large-scale, multicenter randomized controlled trial that includes all non-trauma adult patients. What makes this study unique? Confirmation of Tube Placement: Researchers will use a specific measurement called end-tidal CO2 (etCO2) to confirm the tube is in the right place, a method not used in similar previous studies. Assessing Difficulty: This study will use the Cormack-Lehane classification system to measure how difficult the intubation was for each patient. Standardization: For the first time, breathing machine (ventilator) settings will be standardized for all patients in this type of study. Real-World Practice: By involving all emergency department physicians as practitioners, the study aims to show how these methods work across a wide range of medical teams.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Oct 2025Jun 2026

Study Start

First participant enrolled

October 29, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 15, 2026

Completed
18 days until next milestone

First Posted

Study publicly available on registry

February 2, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 29, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 29, 2026

Last Updated

February 2, 2026

Status Verified

January 1, 2026

Enrollment Period

7 months

First QC Date

January 15, 2026

Last Update Submit

January 24, 2026

Conditions

Keywords

delayed sequence intubationrapid sequence intubationRSIDSI

Outcome Measures

Primary Outcomes (9)

  • Number of Participants with Procedure-Related Adverse Events

    Hypoxia(Spo2\<90), hypotension (systolic blood pressure \<90mmHg or blood pressure drop \>20mmg after intiation of intubation protocol), orogastric intubation, cardiac arrest, orolaryngeal trauma, aspiration of orogastric fluid is accepted as procedure-related adverse events

    During and 1 hours after intubation

  • Mean Peripheral Oxygen Saturation (SpO2)

    Spo2 levels at admission, when intubation decision made, Spo2 level upon commencement of the intubation protocol(0-min); Spo2 level at 1st minute, 2nd minute, 3rd minute of intubation protocol, during blade passes incisor teeth, 1 minutes after intubation, 5 minutes after intubation wil be recorded

    Hospital admission, Intubation decision, Protocol start (0 min), Minutes 1, 2, 3 of protocol, During blade insertion, 1 minute post-intubation, and 5 minutes post-intubation

  • Mean Arterial Blood pH Levels

    Evaluation of acid-base status.

    Hospital admission, At the time of intubation decision, and 15 minutes post-intubation.

  • Mean Partial Pressure of Carbon Dioxide (PaCO2)

    Measure of carbon dioxide in arterial blood.

    Hospital admission, At the time of intubation decision, and 15 minutes post-intubation.

  • Mean Arterial Bicarbonate (HCO3) Concentration

    Measure of bicarbonate in arterial blood.

    Hospital admission, At the time of intubation decision, and 15 minutes post-intubation.

  • Mean Base Excess (BE) Levels

    Measure of base excess in arterial blood.

    Hospital admission, At the time of intubation decision, and 15 minutes post-intubation.

  • Mean Arterial Lactate Concentration

    Measure of lactate in arterial blood.

    Hospital admission, At the time of intubation decision, and 15 minutes post-intubation.

  • First Hour Mortality

    Death from any cause within 60 minutes following the intubation attempt.

    1 hour later intubation

  • 28th day mortality

    All-cause mortality recorded during the first 28 days after enrollment.

    28 days after intubation

Secondary Outcomes (2)

  • Number of intubation attempts

    During the procedure (from the start of the intubation attempt until confirmation of tube placement).

  • Intubation Duration

    During the procedure (from the start of the intubation attempt until confirmation of tube placement).

Study Arms (2)

Delayed Sequence Intubation

EXPERIMENTAL
Procedure: Delayed Sequence Intubation

Rapid Sequence Intubation

ACTIVE COMPARATOR
Procedure: Rapid Sequence Intubation

Interventions

Patients assigned to the Delayed Sequence Intubation (DSI) protocol will receive an initial dose of 1 mg/kg ketamine. Titrated additional doses of 0.5 mg/kg will be administered until 'adequate sedation/dissociation' is achieved, ensuring the preservation of airway reflexes and spontaneous respiration. Subsequently, 'preoxygenation' will be performed for 3 minutes with 'appropriate positioning,' using a non-rebreather mask or bag-valve-mask combined with a nasal cannula delivering maximum oxygen flow (10-15 L/min). Following the induction of paralysis with an intravenous push of rocuronium (1 mg/kg), endotracheal intubation will be performed using direct laryngoscopy. Throughout the protocol, relevant physiological parameters will be recorded on the study data form by a designated physician.

Delayed Sequence Intubation

Patients assigned to the Rapid Sequence Intubation (RSI) protocol will receive 'preoxygenation' for 3 minutes using a non-rebreather mask (NRM) or bag-valve-mask (BVM) combined with a nasal cannula delivering maximum oxygen flow (10-15 L/min), following the necessary preparation period. Subsequently, appropriate sedation and paralysis will be achieved through the sequential administration of intravenous (IV) ketamine (1 mg/kg push) and rocuronium (1 mg/kg IV push). Following induction, endotracheal intubation will be performed via direct laryngoscopy. Throughout the protocol, relevant physiological parameters will be recorded on the study data form by a designated physician

Rapid Sequence Intubation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older
  • Presence of spontaneous breathing.
  • No prediction of a difficult airway prior to intubation.
  • Requirement for advanced airway management.
  • Not in cardiac arrest.
  • Decided to intubate due to non-traumatic etiologies.
  • Planned intubation using ketamine for sedation and rocuronium for paralysis.
  • Decision to intubate due to one of the following clinical conditions:
  • Acute Respiratory Failure: Patients with hypoxic or hypercapnic respiratory failure where adequate oxygenation cannot be achieved despite non-invasive ventilation.
  • Inability to Protect the Airway: Altered level of consciousness or increased risk of pulmonary aspiration due to conditions such as upper gastrointestinal bleeding, ileus, volvulus, gastric outlet obstruction, hypersalivation, or hyperemesis.
  • Shock States: Patients in any state of shock (hypovolemic, distributive, cardiogenic, obstructive) exhibiting severe altered mental status or declining respiratory status.
  • Neuroprotection: Need to terminate ongoing seizures resistant to medical therapy (status epilepticus), or situations requiring strict control of arterial carbon dioxide (PaCO₂) levels to manage increased intracranial pressure (ICP) in non-traumatic conditions (such as intracranial hemorrhage or severe encephalopathy).
  • Obtaining informed consent from the patient or their legally authorized representative.

You may not qualify if:

  • Aged under 18 years.
  • Pregnancy.
  • Refusal to provide informed consent.
  • Cardiac arrest prior to intubation.
  • Anticipated difficult airway.
  • Intubation required due to traumatic etiologies.
  • Missing or incomplete patient data.
  • Patients assigned to the DSI protocol but for whom the decision to intubate was rescinded due to clinical improvement during the preoxygenation phase.
  • Use of a sedative agent other than ketamine for the RSI protocol.
  • Intubations performed by practitioners who have not received study-specific training on DSI and RSI protocols.
  • Duplicate enrollment due to recurrent presentations during the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Basaksehir Cam and Sakura City Hospital

Istanbul, Istanbul, 34170, Turkey (Türkiye)

RECRUITING

İstanbul Haseki Training and Research Hospital

Istanbul, Turkey (Türkiye)

RECRUITING

Kanuni Sultan Süleyman Research and Training Hospital

Istanbul, Turkey (Türkiye)

RECRUITING

Şişli Hamidiye Etfal Training and Research Hospital

Istanbul, Turkey (Türkiye)

RECRUITING

Related Publications (5)

  • Mosier JM, Joshi R, Hypes C, Pacheco G, Valenzuela T, Sakles JC. The Physiologically Difficult Airway. West J Emerg Med. 2015 Dec;16(7):1109-17. doi: 10.5811/westjem.2015.8.27467. Epub 2015 Dec 8.

    PMID: 26759664BACKGROUND
  • Weingart SD, Trueger NS, Wong N, Scofi J, Singh N, Rudolph SS. Delayed sequence intubation: a prospective observational study. Ann Emerg Med. 2015 Apr;65(4):349-55. doi: 10.1016/j.annemergmed.2014.09.025. Epub 2014 Oct 23.

    PMID: 25447559BACKGROUND
  • Weingart SD, Levitan RM. Preoxygenation and prevention of desaturation during emergency airway management. Ann Emerg Med. 2012 Mar;59(3):165-75.e1. doi: 10.1016/j.annemergmed.2011.10.002. Epub 2011 Nov 3.

    PMID: 22050948BACKGROUND
  • Stanke L, Nakajima S, Zimmerman LH, Collopy K, Fales C, Powers W 4th. Hemodynamic Effects of Ketamine Versus Etomidate for Prehospital Rapid Sequence Intubation. Air Med J. 2021 Sep-Oct;40(5):312-316. doi: 10.1016/j.amj.2021.05.009. Epub 2021 Jul 2.

    PMID: 34535237BACKGROUND
  • Sehdev RS, Symmons DA, Kindl K. Ketamine for rapid sequence induction in patients with head injury in the emergency department. Emerg Med Australas. 2006 Feb;18(1):37-44. doi: 10.1111/j.1742-6723.2006.00802.x.

    PMID: 16454773BACKGROUND

MeSH Terms

Interventions

Rapid Sequence Induction and Intubation

Intervention Hierarchy (Ancestors)

Intubation, IntratrachealAirway ManagementTherapeuticsIntubationInvestigative Techniques

Central Study Contacts

Utku Murat Kalafat, Associate Professor

CONTACT

Muhammed Güner, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 15, 2026

First Posted

February 2, 2026

Study Start

October 29, 2025

Primary Completion (Estimated)

May 29, 2026

Study Completion (Estimated)

June 29, 2026

Last Updated

February 2, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

After publication and upon reasonable request

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Data will be available beginning 6 months and ending 36 months after article publication.
Access Criteria
Requests for data should be directed to the principal investigator. To gain access, data requestors will need to sign a data access agreement.

Locations